Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Jan. 01, 2023
Current assets:
Cash and cash equivalents	$ 21,859	$ 12,889
Marketable securities	1,068	9,392
Accounts receivable trade, less allowances $166 (2022, $169)	14,873	14,039
Inventories	11,181	10,268
Prepaid expenses and other receivables	4,514	2,876
Total current assets of discontinued operations	0	5,830
Total current assets	53,495	55,294
Property, plant and equipment, net	19,898	17,982
Intangible assets, net	34,175	38,489
Goodwill	36,558	36,047
Deferred taxes on income	9,279	8,947
Other assets	14,153	9,212
Noncurrent assets of discontinued operations	0	21,407
Total assets	167,558	187,378
Current liabilities
Loans and notes payable	3,451	12,756
Accounts payable	9,632	9,889
Accrued liabilities	10,212	10,719
Accrued rebates, returns and promotions	16,001	13,579
Accrued compensation and employee related obligations	3,993	3,049
Accrued taxes on income	2,993	2,220
Current liabilities of discontinued operations	0	3,590
Total current liabilities	46,282	55,802
Long-term debt	25,881	26,886
Deferred taxes on income	3,193	3,991
Employee related obligations	7,149	6,542
Long-term taxes payable	2,881	4,306
Other liabilities	13,398	10,146
Noncurrent liabilities of discontinued operations	0	2,901
Total liabilities	98,784	110,574
Commitments and Contingencies
Shareholders’ equity
Preferred stock — without par value (authorized and unissued 2,000,000 shares)	0	0
Common stock — par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)	3,120	3,120
Accumulated other comprehensive income (loss)	(12,527)	(12,967)
Retained earnings and Additional-paid-in-capital	153,843	128,345
Less: common stock held in treasury, at cost (Note 12) (712,765,000 shares and 506,246,000 shares)	75,662	41,694
Total shareholders’ equity	68,774	76,804
Total liabilities and shareholders’ equity	$ 167,558	$ 187,378